Cargando…
Bioprocess development of antibody-drug conjugate production for cancer treatment
Antibody-drug conjugate (ADC) is a class of targeted cancer therapies that combine the advantages of monoclonal antibody (mAb)’s specific targeting and chemotherapy’s potent cytotoxicity. The therapeutic effect of ADC is significantly affected by its bioproduction process. This study aims to develop...
Autores principales: | Ou, Jianfa, Si, Yingnan, Goh, KahYong, Yasui, Norio, Guo, Yichen, Song, Jiajia, Wang, Lizhong, Jaskula-Sztul, Renata, Fan, Jinda, Zhou, Lufang, Liu, Runhua, Liu, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198984/ https://www.ncbi.nlm.nih.gov/pubmed/30352095 http://dx.doi.org/10.1371/journal.pone.0206246 |
Ejemplares similares
Cargando…
Bioprocess engineering : basic concepts /
por: Shuler, Michael L., 1947-
Publicado: (2002)
por: Shuler, Michael L., 1947-
Publicado: (2002)
Ejemplares similares
-
Anti-SSTR2 Antibody-drug Conjugate for Neuroendocrine Tumor Therapy
por: Si, Yingnan, et al.
Publicado: (2020) -
Antibody–Drug Conjugate to Treat Meningiomas
por: Chen, Kai, et al.
Publicado: (2021) -
Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment
por: Si, Yingnan, et al.
Publicado: (2020) -
2018 Synaptic vesicle 2 receptors as a novel targets for
neuroendocrine cancer therapy
por: Jaskula-Sztul, Renata, et al.
Publicado: (2018) -
Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
por: Si, Yingnan, et al.
Publicado: (2021)